Reading time is 2 mins
.
.
IT WAS FEARED: THE ALARM OF THE NEW CORONA VIRUS VARIANT IN EUROPE
The corona virus continues to mutate from the first day of its appearance, increasing its effect with new variants. New measures have been put in place due to the Omicron variant, which has alarmed the whole world, especially Europe, while the feared news has come from France. French authorities have announced that they have come across a new variant of the corona virus in Marseille.
While there was concern about the Omicron variant of the corona virus all over the world, there was a frightening news from France.
France announced that they had encountered 12 cases with the new mutation, the first of which was from a passenger traveling from the African country of Cameroon.
The variant was first noticed on December 10, 2021 by scientists at the Méditerranée Infection University Hospital Institute (IHU) on patients in the Alpes-de-Haute region. 12 cases in which this ‘non-typical combination’ variant was detected near the Marseille region have also been recorded. According to Professor the head of the department who first identified the situation, the variant was called the ‘IHU variant’.
.
MORE RESISTANT TO THE VACCINE
The scientists explained that this new mutant variant has 46 mutations that are both more resistant to the vaccine and more contagious.
However, experts believe that the Omicron variant, which currently accounts for more than 60 percent of cases in France, is still dominant.
Similar symptoms and a variant of IHU were detected in 12 people who arrived in France from the African country of Cameroon. The detection of cases in Marseille surprised scientists.
The new variant has not yet been detected in a different country and is not a variant being investigated by the World Health Organization, it said.
.
THE NAME OF THE VARIANT IS IHU
Professor, head of the unit that discovered the new variant, said in a statement: “Indeed, there are several cases of this new variant in the Marseille geographical region. We have named it “variant IHU”. Two new genomes have just been sent.” said.
Among the 46 mutations, E484K and N DEC01Y mutations were observed in the tests performed on the variant. It is known that the first is more resistant to the vaccine, the second mutation detected in the Alpha variant of the first also increases the infectiousness.
.
DESCRIPTION OF THE NEW IHU VARIANT IN EUROPE FROM WHO
The WHO has issued a comforting statement regarding the new variant that has been detected in Europe and is causing concern.
The World Health Organization (WHO) reports that the variant detected in France, which caused concern, is not a major threat.
The variant in question was first detected in November 2021 and has not posed a major threat since, WHO official said, “The variant is on our radar. He had many chances to move forward,” he said.
The news that the new Covid-19 variant with 46 mutations has a high rate of spread and is resistant to the vaccine had caused concern.
The new variant, identified in the same period as the Omicron variant that appeared in South Africa and led to a record-breaking number of cases in many countries, was first seen in 12 people in France.
Scientists at the Méditerranée Infection University Hospital Institute (IHU), who identified the new variant, had published a paper at the end of December 2021 in which they drew attention to atypical mutations. “It is too early to make claims about the virological, epidemiological and clinical characteristics of this new IHU variant,” was said.
.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.